These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5649556)

  • 1. Potentiation and blockade of the central action of amphetamine by chlorpromazine.
    Sulser F; Dingell JV
    Biochem Pharmacol; 1968 Apr; 17(4):634-6. PubMed ID: 5649556
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of certain effects of amphetamine by chlorpromazine.
    Borella L; Herr F; Wojdan A
    Can J Physiol Pharmacol; 1969 Jan; 47(1):7-13. PubMed ID: 5761849
    [No Abstract]   [Full Text] [Related]  

  • 3. Time-related interaction patterns of amphetamine with reserpine and other central depressants.
    Banerjee U; Geh SL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):109-22. PubMed ID: 4739077
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of haloperidol and chlorpromazine on amphetamine metabolism and amphetamine stereotype behavior in the rat.
    Lemberger L; Witt ED; Davis JM; Kopin IJ
    J Pharmacol Exp Ther; 1970 Sep; 174(3):428-33. PubMed ID: 5456175
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ammonium chloride on the potentiation of amphetamine by psychotropic drugs in the rat.
    Borella LE; Herr F
    Biochem Pharmacol; 1971 Mar; 20(3):589-95. PubMed ID: 5150156
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chlorpromazine on the disposition and excretion of amphetamine in the rat.
    Borella LE; Pinski J; Herr F
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):667-76. PubMed ID: 5524269
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral effects of a new psychoactive drug (d-carbine) on a passive avoidance response and locomotion and its interaction with amphetamine.
    Barkov N; Geller A; Jarvik ME
    Psychopharmacologia; 1971; 21(1):82-8. PubMed ID: 5567293
    [No Abstract]   [Full Text] [Related]  

  • 9. Striatal homovanillic acid levels in rats after combined treatments with amphetamine and neuroleptics.
    Fuentes JA; Del Rio J
    Eur J Pharmacol; 1972 Feb; 17(2):297-300. PubMed ID: 5026405
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J; Buczko W
    Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of some CNS depressants on the hypermotility and anorexia induced by amphetamine in rats.
    Borella LE; Paquette R; Herr F
    Can J Physiol Pharmacol; 1969 Oct; 47(10):841-7. PubMed ID: 5259591
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification by propranolol and related compounds of motor activity and stereotype behaviour induced in the rat by amphetamine.
    Weinstock M; Speiser Z
    Eur J Pharmacol; 1974 Jan; 25(1):29-35. PubMed ID: 4279823
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.
    Crow TJ; Gillbe C
    Nat New Biol; 1973 Sep; 245(140):27-8. PubMed ID: 4516939
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a dopamine beta-hydroxylase inhibitor on amphetamine-induced hyperactivity in rats.
    Khalsa JH; Davis WM
    J Pharm Pharmacol; 1975 Aug; 27(8):620-2. PubMed ID: 239183
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.
    Rastogi RB; Lapierre YD; Singhal RL; Nair NP
    Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443
    [No Abstract]   [Full Text] [Related]  

  • 16. Study on the excitation induced by amphetamine, cocaine and alpha-methyltryptamine.
    Galambos E; Pfeifer AK; György L; Molnár J
    Psychopharmacologia; 1967; 11(2):122-9. PubMed ID: 5588184
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellum.
    Ferrendelli JA; Kinscherf DA; Kipnis DM
    Biochem Biophys Res Commun; 1972 Mar; 46(6):2114-20. PubMed ID: 4336236
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic interaction of psychotropic drugs. I. Divergent effect of mianserin on pharmacokinetics and pharmacodynamics of amphetamine.
    Chodera A; Cenajek D; Godlewski J
    Pol J Pharmacol Pharm; 1979; 31(6):609-13. PubMed ID: 575858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased release of dopane from striatal dopaminergic terminals in the rat after treatment with a neuroleptic: thioproperazine.
    Cheramy A; Besson MJ; Glowinski J
    Eur J Pharmacol; 1970 May; 10(2):206-14. PubMed ID: 4392817
    [No Abstract]   [Full Text] [Related]  

  • 20. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.
    Freeman JJ; Sulser F
    J Pharmacol Exp Ther; 1972 Nov; 183(2):307-15. PubMed ID: 4673401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.